MitraClip for High Risk MR Patients
EVEREST II High Risk Study in patients with estimated surgical mortality risk of more than 12%.
Peter C. Block, M.D., F.A.C.C.
Statements or opinions expressed in this program reflects the views of the contributors
and
do not reflect the official policy of the ACCF, unless otherwise noted.